Crossmark

Perspectives on cancer therapy—synthetic lethal precision medicine strategies, molecular mechanisms, therapeutic targets and current technical challenges

Crossref DOI link: https://doi.org/10.1038/s41420-025-02418-8

Published Online: 2025-04-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Peng, Shixuan

Long, Mengle

Chen, Qisheng

Yin, Zhijian

Zeng, Chang

Zhang, Wanyong

Wen, Qingyang

Zhang, Xinwen https://orcid.org/0000-0003-0874-1914
Ke, Weiqi https://orcid.org/0000-0001-9079-1915
Wu, Yongjun https://orcid.org/0009-0001-8009-5526
License Information

Text and Data Mining valid from 2025-04-16

Version of Record valid from 2025-04-16
More Information

Article History

Received: 17 November 2024

Revised: 27 February 2025

Accepted: 19 March 2025

First Online: 16 April 2025

Competing interests

: The authors declare no competing interests.

: Not applicable.

: Not applicable.

Document is current

Any future updates will be listed below